Simplify Logo

Full-Time

Regional Sales Manager

New Jersey

Confirmed live in the last 24 hours

Revance

Revance

501-1,000 employees

Biotechnology company for aesthetic solutions

Healthcare
Biotechnology
Fintech

Compensation Overview

$140k - $160kAnnually

+ Uncapped Commissions

Senior, Expert

Trenton, NJ, USA

Ability to travel up to 50%+ within the New Jersey region.

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Management
Marketing
Requirements
  • Doctorate degree & 2 years of sales management experience OR Master’s degree & 4 years of sales management experience OR Bachelor’s degree & 7 years of sales management experience AND 2 years of managerial experience directly managing people, projects, programs or resources
Responsibilities
  • Attain or exceed sales plan through motivation and activation of field sales representatives
  • Attract and retain top sales representative
  • Proactively develop and cultivate a positive working culture
  • Monitor field activity to ensure balanced workloads; exercise control over resources, budgets, and expenses; oversee business operations including accounts receivable, etc.
  • Execute key sales and marketing strategies
  • Build and nurture relationships with KOLs
  • Provide and filter key market insights back to sales and marketing management
  • Maintain reporting, records, and files necessary for proper management of the sales region
  • Positively represent Revance throughout customer locations
  • Actively participate in scheduled company sales meetings, conference calls, and other necessary business meetings
  • Demonstrate honesty and integrity while modeling behaviors consistent with company standards and policies for business and compliance

Revance Therapeutics, Inc. specializes in aesthetic and therapeutic solutions, primarily focusing on products that enhance physical appearance and improve patient outcomes. The company offers neuromodulators, like botulinum toxin type A, which reduce wrinkles and treat muscle movement disorders, and dermal fillers that restore volume and smooth facial lines. Revance is also exploring therapeutic uses for its products in muscle movement and pain disorders. Additionally, the company has expanded into the fintech sector with the acquisition of HintMD, a platform that streamlines payment processes for aesthetic practices. This integration allows Revance to provide a comprehensive suite of services to support aesthetic practitioners. Unlike its competitors, Revance emphasizes differentiated products and improved patient experiences, aiming to establish itself as a leader in the premium aesthetics market.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Nashville, Tennessee

Founded

1999

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-12%

2 year growth

9%
Simplify Jobs

Simplify's Take

What believers are saying

  • Revance's partnership with Viatris to commercialize DAXXIFY in China opens up significant international market opportunities.
  • The launch of DAXXIFY for cervical dystonia treatment positions Revance as a key player in the U.S. therapeutics neurotoxin market.
  • The company's $100 million public offering indicates strong investor confidence and provides capital for further expansion and innovation.

What critics are saying

  • The biotech and aesthetics markets are highly competitive, requiring continuous innovation to maintain market share.
  • Regulatory hurdles and FDA approvals can delay product launches and impact revenue streams.

What makes Revance unique

  • Revance's integration of fintech solutions like HintMD into its aesthetic offerings provides a unique value proposition that competitors in the biotech space lack.
  • The company's focus on both aesthetic and therapeutic applications for neuromodulators and dermal fillers sets it apart from competitors who may focus solely on one area.
  • Revance's recent launch of DAXXIFY for cervical dystonia treatment highlights its commitment to expanding into therapeutic markets, differentiating it from purely aesthetic-focused companies.